EUVIMEDEUVIMED entdecken
Open Access

Design, synthesis, and biological evaluation of novel coumarine-1,2,3-triazole hybrids as dual DNA gyrase/superoxide dismutase inhibitors: molecular docking, DFT, and ADMET investigations

Gaurav B Patel, Yogesh O Bhola, Piyush V Dholaria, Arvindbhai R Suthar, Dhavalkumar M Bhatt

Future Medicinal Chemistry · 18.06.2026 · 18 (12) · 1559-1570

DOI: 10.1080/17568919.2026.2669609 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Medicinal Chemistry, online erschienen am 06.05.2026. Verfasst von Gaurav B Patel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Process and GMP Manufacturing Chemist-III, NJ Bio Inc, Princeton, NJ, USA. Hauptthemen laut MEDLINE: Triazoles, Coumarins, Superoxide Dismutase, DNA Gyrase. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of eight novel coumarin-1,2,3-triazole hybrid derivatives (6a-h) were synthesized and evaluated for their antimicrobial and antioxidant potentials through in vitro and in silico approaches. Molecular docking studies against DNA gyrase subunit B (PDB ID: 7P2M) revealed that compounds 6b and 6h exhibited superior-binding affinities with docking scores of -5.448 and -5.106 kcal/mol, respectively, surpassing ciprofloxacin (-4.992 kcal/mol). Against superoxide dismutase [Cu-Zn] (PDB ID: 1PU0), compound 6h showed the highest binding affinity (-4.157 kcal/mol), comparable to ascorbic acid (-3.787 kcal/mol). Antimicrobial screening demonstrated that compound 6b displayed potent broad-spectrum activity with MIC values of 50-100 µg/mL against E. coli, P. aeruginosa, S. aureus, and S. pyogenes. Antioxidant evaluation using the DPPH assay showed compound 6g exhibited the highest activity (IC50 = 54.89 ± 1.2 µg/mL), approaching ascorbic acid (52.66 ± 0.8 µg/mL). DFT calculations for compound 6b revealed favorable electronic properties with a HOMO-LUMO energy gap of 3.445 eV and an electrophilicity index of 5.8303 eV. ADMET profiling using SwissADME, ADMETlab 3.0, and ProTox 3.0 demonstrated acceptable drug-likeness parameters, favorable absorption characteristics, and low toxicity profiles. These coumarine-1,2,3-triazole hybrids represent moderate-potency antibacterial and antioxidant scaffolds warranting further structural optimization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TriazolesCoumarinsSuperoxide DismutaseDNA GyraseAnti-Bacterial AgentsDrug DesignTopoisomerase II InhibitorsDensity Functional TheoryMolecular Docking SimulationMicrobial Sensitivity TestsStructure-Activity RelationshipAntioxidantsMolecular Structure

Stichwörter der Autor:innen

1,2,3-triazoleDFTantimicrobial activityantioxidant activitycoumarinemolecular docking

Substanzen

TriazolesCoumarinsSuperoxide DismutaseDNA GyraseAnti-Bacterial AgentsTopoisomerase II InhibitorsAntioxidants

Autor:innen und Institutionen

  • Process and GMP Manufacturing Chemist-III, NJ Bio Inc, Princeton, NJ, USA.
  • Department of Chemistry, Shri M.P. Pandya Science College-Lunawada, Shri Govind Guru University, Godhra, India.
  • Chemistry Division, Sheth M.N. Science College, Hemchandracharya North Gujarat University, Patan, India.
  • Chemistry Department, M. N. College, Visnagar, India.
  • Department of Radiology, Columbia University Mailman School of Public Health, New York, NY, USA.

Zitieren

APA

Patel, G. B., Bhola, Y. O., Dholaria, P. V., Suthar, A. R., & Bhatt, D. M. (2026). Design, synthesis, and biological evaluation of novel coumarine-1,2,3-triazole hybrids as dual DNA gyrase/superoxide dismutase inhibitors: molecular docking, DFT, and ADMET investigations. Future Medicinal Chemistry, 18(12), 1559-1570. https://doi.org/10.1080/17568919.2026.2669609

Vancouver

Patel GB, Bhola YO, Dholaria PV, Suthar AR, Bhatt DM. Design, synthesis, and biological evaluation of novel coumarine-1,2,3-triazole hybrids as dual DNA gyrase/superoxide dismutase inhibitors: molecular docking, DFT, and ADMET investigations. Future Medicinal Chemistry. 2026;18(12):1559-1570. doi:10.1080/17568919.2026.2669609

BibTeX
@article{Patel2026,
  author = {Patel, Gaurav B and Bhola, Yogesh O and Dholaria, Piyush V and Suthar, Arvindbhai R and Bhatt, Dhavalkumar M},
  title = {Design, synthesis, and biological evaluation of novel coumarine-1,2,3-triazole hybrids as dual DNA gyrase/superoxide dismutase inhibitors: molecular docking, DFT, and ADMET investigations},
  journal = {Future Medicinal Chemistry},
  year = {2026},
  volume = {18},
  number = {12},
  pages = {1559--1570},
  doi = {10.1080/17568919.2026.2669609}
}
Kostenlos starten →